Invo Bioscience (OTCQB:IVOB) today announced that it has appointed Andrea Goren as CFO.
Goren has more than 27 years of experience in finance. He has held a number of leadership roles at Phoenix Group, Shamrock Group and Madison Capital Group.
“Andrea has been serving Invo over the past year in a consulting capacity and thus is familiar with the operations of the company, including many within the finance function,” CEO Steve Shum said in a news release. “As he takes over as our permanent CFO, he will continue to interface with our current outside CFO consulting firm to assure a seamless transition. His well-rounded skill set will benefit Invo as we continue to successfully execute on our strategic business plan, including the operational launch of our various company-owned Invo clinics set for the second half of this year.”